Advertisement

Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment

0

Remibrutinib results in significant improvement in composite measure of itching and hives at week 12 after second-generation H1-antihistamine treatment

Free COVID-19 Test Program Stops Taking Orders

0
By I. Edwards HealthDay Reporter TUESDAY, March 11, 2025 (HealthDay News) -- The U.S. government program that provides free at-home COVID tests is no longer...

NIH Cuts Funding for Studies on Vaccine Hesitancy and Acceptance

0
By I. Edwards HealthDay Reporter TUESDAY, March 11, 2025 (HealthDay News) -- The National Institutes of Health (NIH) is cutting or canceling more than 40...

Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM

0

GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin

Treating Male Partners Reduces Recurrence in Bacterial Vaginosis

0

Addition of antimicrobial therapy for male partners to treatment of women results in lower rate of recurrence

CDC to Study Vaccines and Autism, Despite Much Research Showing No Link

0
By I. Edwards HealthDay Reporter MONDAY, March 10, 2025 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention (CDC) is preparing to study...

Recent Decade Saw No Change in Diabetes Prevalence in U.S. Adults

0

However, glycemic control worsened, with the trend most pronounced among younger adults aged 20 to 44 years

Makers of Wegovy & Zepbound Cut Prices for Those Without Insurance

0
By I. Edwards HealthDay Reporter FRIDAY, March 7, 2025 (HealthDay News) -- The makers of two popular weight-loss drugs — Wegovy and Zepbound — are...

No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia

0

No significant difference seen in odds of postoperative pneumonia between adult GLP-1 receptor agonist users and nonusers

Intraoperative Remifentanil, Sufentanil Tied to Poor Postoperative Pain Experience

0

Other predictors of poor pain experience include American Society of Anesthesiologists 3 status, postoperative anxiolytic use, amnesia